Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Illumina Laboratory Services, |
RCV000314539 | SCV000396460 | uncertain significance | HNSHA due to aldolase A deficiency | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001311443 | SCV000520326 | likely benign | not provided | 2019-11-11 | criteria provided, single submitter | clinical testing | |
Mendelics | RCV000314539 | SCV001140087 | likely benign | HNSHA due to aldolase A deficiency | 2019-05-28 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001311443 | SCV001501612 | likely benign | not provided | 2024-07-01 | criteria provided, single submitter | clinical testing | ALDOA: BP4, BS2 |
Mayo Clinic Laboratories, |
RCV001311443 | SCV001716259 | uncertain significance | not provided | 2022-05-11 | criteria provided, single submitter | clinical testing | BS1 |
Labcorp Genetics |
RCV000314539 | SCV001732401 | benign | HNSHA due to aldolase A deficiency | 2024-01-31 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV000314539 | SCV003799740 | likely benign | HNSHA due to aldolase A deficiency | 2022-03-22 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003940251 | SCV004749426 | likely benign | ALDOA-related disorder | 2019-12-09 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
Genome |
RCV000314539 | SCV002075086 | not provided | HNSHA due to aldolase A deficiency | no assertion provided | phenotyping only | Variant interpreted as Uncertain significance and reported on 10-14-2017 by Lab or GTR ID 26957. GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant. |